Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-06
DOI
10.1038/s41467-021-24979-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain
- (2021) Javier Garralda Fernandez et al. PLoS One
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike
- (2021) Jenna J. Guthmiller et al. mBio
- Ebola virus antibody decay–stimulation in a high proportion of survivors
- (2021) Charlene Adaken et al. NATURE
- Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
- (2021) Carlota Dobaño et al. Translational Research
- Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan
- (2021) Masaru Takeshita et al. VIROLOGY
- Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
- (2021) Matthias Becker et al. Nature Communications
- SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
- (2021) Benjamin Trinité et al. Scientific Reports
- SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
- (2021) Jun Wu et al. Nature Communications
- Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
- (2021) Carlota Dobaño et al. BMC Medicine
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
- (2020) Andrea Padoan et al. CLINICA CHIMICA ACTA
- SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence
- (2020) Gerco den Hartog et al. JOURNAL OF INFECTIOUS DISEASES
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
- (2020) Alberto L. Garcia-Basteiro et al. Nature Communications
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset
- (2020) Patrícia Figueiredo‐Campos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection
- (2020) Dorothea Orth-Höller et al. JOURNAL OF INFECTION
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
- (2020) Yun Tan et al. Frontiers of Medicine
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
- (2020) Jaume Barallat et al. PLoS One
- InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams
- (2015) Henry Heberle et al. BMC BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started